Biotricity, Inc. (BTCY)
USD 0.35
(3.83%)
USD 0.35
(3.83%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -8.82 Million USD | 42.24% |
| 2023 | -15.4 Million USD | 12.81% |
| 2022 | -18.02 Million USD | -33.21% |
| 2021 | -13.35 Million USD | -22.95% |
| 2020 | -10.93 Million USD | -27.02% |
| 2019 | -8.59 Million USD | -11.24% |
| 2018 | - USD | -29.98% |
| 2017 | -5.94 Million USD | -15.83% |
| 2016 | -5.12 Million USD | -5625.58% |
| 2015 | - USD | 0.36% |
| 2014 | -89.92 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - USD | 45.74% |
| 2024 Q1 | -2.29 Million USD | -3.03% |
| 2024 Q3 | -1.18 Million USD | 45.22% |
| 2024 Q4 | -2.94 Million USD | -130.02% |
| 2024 Q2 | -2.32 Million USD | -5.05% |
| 2023 Q3 | -4.36 Million USD | -7.39% |
| 2023 Q2 | -4.06 Million USD | 1.78% |
| 2023 FY | - USD | 12.81% |
| 2023 Q1 | -4.13 Million USD | 19.68% |
| 2023 Q4 | -2.22 Million USD | 49.0% |
| 2022 Q4 | -5.15 Million USD | -3.05% |
| 2022 Q3 | -4.99 Million USD | 16.48% |
| 2022 Q2 | -5.98 Million USD | -98.08% |
| 2022 Q1 | -3.02 Million USD | 24.77% |
| 2022 FY | - USD | -33.21% |
| 2021 Q1 | -3.57 Million USD | 20.06% |
| 2021 FY | - USD | -22.95% |
| 2021 Q2 | -2.84 Million USD | 20.25% |
| 2021 Q3 | -3.86 Million USD | -35.79% |
| 2021 Q4 | -4.01 Million USD | -3.82% |
| 2020 Q2 | -2 Million USD | 3.9% |
| 2020 Q3 | -2.34 Million USD | -16.85% |
| 2020 FY | - USD | -27.02% |
| 2020 Q1 | -2.08 Million USD | -14.65% |
| 2020 Q4 | -4.46 Million USD | -90.48% |
| 2019 Q1 | -2.42 Million USD | 13.29% |
| 2019 FY | - USD | -11.24% |
| 2019 Q3 | -2.17 Million USD | 0.21% |
| 2019 Q2 | -2.17 Million USD | 10.07% |
| 2019 Q4 | -1.82 Million USD | 16.1% |
| 2018 Q1 | -1.33 Million USD | 13.36% |
| 2018 Q2 | -1.45 Million USD | -8.6% |
| 2018 Q3 | -2.09 Million USD | -44.04% |
| 2018 Q4 | -2.79 Million USD | -33.21% |
| 2018 FY | - USD | -29.98% |
| 2017 Q1 | -800.8 Thousand USD | -38.88% |
| 2017 Q4 | -1.54 Million USD | 29.46% |
| 2017 FY | - USD | -15.83% |
| 2017 Q3 | -2.19 Million USD | -56.24% |
| 2017 Q2 | -1.4 Million USD | -75.21% |
| 2016 Q2 | -1.22 Million USD | -149.3% |
| 2016 FY | - USD | -5625.58% |
| 2016 Q4 | -576.62 Thousand USD | 59.86% |
| 2016 Q3 | -1.43 Million USD | -17.11% |
| 2016 Q1 | -492.01 Thousand USD | 0.0% |
| 2015 Q1 | -27.64 Thousand USD | 0.0% |
| 2015 Q2 | -20.58 Thousand USD | 25.52% |
| 2015 Q3 | -18.9 Thousand USD | 8.18% |
| 2015 FY | - USD | 0.36% |
| 2014 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 34.542% |
| Cerus Corporation | -26.53 Million USD | 66.731% |
| OrthoPediatrics Corp. | -8.38 Million USD | -5.337% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 15.877% |
| Talis Biomedical Corporation | -66.04 Million USD | 86.633% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 47.057% |
| Inogen, Inc. | -45.67 Million USD | 80.673% |
| Spectral AI, Inc. | -12.26 Million USD | 28.003% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 81.489% |
| CVRx, Inc. | -38.73 Million USD | 77.206% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -150.234% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 27.081% |
| Orthofix Medical Inc. | -86.98 Million USD | 89.851% |
| Venus Concept Inc. | -26.11 Million USD | 66.192% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 82.262% |
| Bioventus Inc. | -23.07 Million USD | 61.733% |
| BrainsWay Ltd. | -2.31 Million USD | -282.011% |
| Envoy Medical, Inc. | -18.23 Million USD | 51.594% |
| electroCore, Inc. | -17.76 Million USD | 50.291% |
| IceCure Medical Ltd | -15.25 Million USD | 42.121% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 82.255% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 47.624% |
| MaxCyte, Inc. | -44.12 Million USD | 79.994% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 24.904% |
| Nexalin Technology, Inc. | -5.69 Million USD | -55.098% |
| PAVmed Inc | -75.74 Million USD | 88.344% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 83.578% |
| RxSight, Inc. | -41.03 Million USD | 78.487% |
| Sight Sciences, Inc. | -49.41 Million USD | 82.134% |
| SI-BONE, Inc. | -34.44 Million USD | 74.371% |
| TELA Bio, Inc. | -40.63 Million USD | 78.273% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 84.857% |
| Treace Medical Concepts, Inc. | -39 Million USD | 77.368% |
| LivaNova PLC | 39.01 Million USD | 122.627% |
| 908 Devices Inc. | -34.02 Million USD | 74.054% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 92.017% |
| Nemaura Medical Inc. | -7.28 Million USD | -21.15% |
| NeuroPace, Inc. | -22.83 Million USD | 61.337% |
| LENSAR, Inc. | -8.71 Million USD | -1.311% |
| Apyx Medical Corporation | -18.11 Million USD | 51.257% |
| Cutera, Inc. | -136.56 Million USD | 93.535% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -161.191% |
| BioSig Technologies, Inc. | -28.15 Million USD | 68.64% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 450.885% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 57.939% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 102.302% |
| Axonics, Inc. | 7.77 Million USD | 213.547% |
| Outset Medical, Inc. | -153.78 Million USD | 94.259% |
| IRIDEX Corporation | -7.44 Million USD | -18.532% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 91.0% |
| IRadimed Corporation | 20.8 Million USD | 142.442% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -9.505% |
| INVO Bioscience, Inc. | -6.88 Million USD | -28.317% |
| Telesis Bio, Inc. | -40.49 Million USD | 78.198% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 124.07% |
| Varex Imaging Corporation | 67.2 Million USD | 113.137% |
| Quipt Home Medical Corp. | 44.07 Million USD | 120.032% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 18.783% |
| Pulmonx Corporation | -55.09 Million USD | 83.975% |
| Dynatronics Corporation | -976 Thousand USD | -804.528% |
| Modular Medical, Inc. | -17.1 Million USD | 48.382% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 39.052% |
| Semler Scientific, Inc. | 23.58 Million USD | 137.425% |
| InMode Ltd. | 196.28 Million USD | 104.498% |
| Bruker Corporation | 599 Million USD | 101.474% |
| Cytosorbents Corporation | -28.81 Million USD | 69.358% |
| DexCom, Inc. | 916.7 Million USD | 100.963% |
| Align Technology, Inc. | 799.03 Million USD | 101.105% |
| Viveve Medical, Inc. | -20.61 Million USD | 57.18% |
| ZimVie Inc. | 91.07 Million USD | 109.694% |
| Movano Inc. | -29.12 Million USD | 69.688% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -100.278% |
| Nexalin Technology, Inc. | -5.69 Million USD | -55.098% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -150.234% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 95.465% |
| Profound Medical Corp. | -27.12 Million USD | 67.452% |
| Insulet Corporation | 323.6 Million USD | 102.728% |
| enVVeno Medical Corporation | -25.01 Million USD | 64.712% |
| Surmodics, Inc. | 1.18 Million USD | 843.12% |
| iCAD, Inc. | -6.56 Million USD | -34.475% |
| Nuwellis, Inc. | -16.35 Million USD | 46.024% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 90.886% |
| Aethlon Medical, Inc. | -11.84 Million USD | 25.494% |
| InspireMD, Inc. | -20.91 Million USD | 57.782% |
| PAVmed Inc. | -75.74 Million USD | 88.344% |
| BIOLASE, Inc. | -15.13 Million USD | 41.685% |
| Beyond Air, Inc. | -59.03 Million USD | 85.045% |
| FONAR Corporation | 28.25 Million USD | 131.249% |
| AxoGen, Inc. | -13.32 Million USD | 33.761% |
| Vivani Medical, Inc. | -26.6 Million USD | 66.821% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 135.974% |
| Inari Medical, Inc. | 7.11 Million USD | 224.115% |
| UFP Technologies, Inc. | 72.74 Million USD | 112.136% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -160.745% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -43.409% |
| Tenon Medical, Inc. | -15.52 Million USD | 43.146% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 42.17% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 78.715% |
| AdaptHealth Corp. | -171.09 Million USD | 94.84% |
| Sintx Technologies, Inc. | -6.6 Million USD | -33.762% |
| NanoVibronix, Inc. | -3.43 Million USD | -157.009% |
| Quanterix Corporation | -38.08 Million USD | 76.821% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 18.783% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 29527.563% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 96.816% |
| TransMedics Group, Inc. | -7.6 Million USD | -16.116% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 59.438% |
| NeuroMetrix, Inc. | -7.09 Million USD | -24.415% |
| Hyperfine, Inc. | -47.06 Million USD | 81.241% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 84.859% |
| Biomerica, Inc. | -5.99 Million USD | -47.31% |
| Bone Biologics Corporation | 479.57 Thousand USD | 1940.864% |
| AVITA Medical, Inc. | -39.56 Million USD | 77.688% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 3.757% |
| Silk Road Medical, Inc | -45.08 Million USD | 80.416% |